O
EYPT icon

OrbiMed’s EyePoint Inc EYPT Stock Holding History

OrbiMed’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Hold
1,069,147
– – 0.28% 75
2026
Q1 		$13.8M Sell
1,069,147
-1,399,167
-57% -$20.9M 0.27% 70
2025
Q4 		$45.1M Buy
2,468,314
+672,314
+37% +$9.53M 0.92% 33
2025
Q3 		$25.6M Buy
+1,796,000
New +$20.7M 0.6% 48
2023
Q1 		– Sell
-487,642
Closed -$1.71M – 132
2022
Q4 		$1.71M Sell
487,642
-483,218
-50% -$2.13M 0.03% 105
2022
Q3 		$7.68M Buy
970,860
+756,760
+353% +$7.03M 0.14% 94
2022
Q2 		$1.69M Buy
+214,100
New +$2.15M 0.03% 135

Other funds holding EYPT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OrbiMed's EYPT Position: Q2 2026 in Review

OrbiMed held its EyePoint Inc (EYPT) position steady in Q2 2026 at 1,069,147 shares worth $15.3M. The position accounts for 0.28% of the portfolio, ranked #75.

OrbiMed first reported a position in EYPT in Q2 2022 and has held it in 7 quarters since. The position peaked at $45.1M in Q4 2025. 189 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

  • OrbiMed held 1,069,147 shares of EyePoint Inc worth $15.3M as of Q2 2026.
  • OrbiMed left its EyePoint Inc share count unchanged in Q2 2026.
  • EyePoint Inc made up 0.28% of OrbiMed's portfolio in Q2 2026, its #75 holding.
  • OrbiMed first reported a position in EyePoint Inc in Q2 2022 and has held it in 7 quarters since.
  • OrbiMed's EyePoint Inc position peaked at $45.1M in Q4 2025.
  • 189 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.